References
- Bateman DN, Page CB. Antidotes to coumarins, isoniazid, methotrexate and thyroxine, toxins that work via metabolic processes. Br J Clin Pharmacol. 2016;81:437–445.
- Balis FM, Savitch SL, Bleyer WA. Pharmacokinetics of oral methotrexate in children. Cancer Res. 1983;43:2342–2345.
- Chan BS, Dawson AH, Buckley NA. What can clinicians learn about therapeutic studies about the treatment of acute oral methotrexate poisoning? Clin Toxicol. 2017;55:88–96.
- Bleyer WA. New vistas for leucovorin in cancer chemotherapy. Cancer. 1989;63:995–1007.
- Bleyer WA. Methotrexate: clinical pharmacology, current status and therapeutic guideline. Cancer Treat Rev.1977;4:87–101.
- Cao M, Guo M, Wu DQ, et al. Pharmacogenomics of methotrexate: current status and future outlook. Curr Drug Metab. 2017 [Dec 27]. DOI:10.2174/1389200219666171227201047. [Epub ahead of print].